How severe is CVE-2022-48225?

CVE-2022-48225 has a CVSS 3.x base score of 7.3, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-48225 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-48225?

CVE-2022-48225 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-48225?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-48225 published?

CVE-2022-48225 was published on 2023-04-04 and last updated on 2026-06-17.

CVE-2022-48225

CVE-2022-48225 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk with a CVSS 3.x base score of 7.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-427.

Key facts

Severity: High (CVSS 3.x base score 7.3)
EPSS exploit prediction: 0% (10th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-427
Affected product: Gbgplc Acuant Acufill Sdk
Published: 2023-04-04
Last modified: 2026-06-17

Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is used to install drivers from several different vendors. The Gemalto Document Reader child installation process is vulnerable to DLL hijacking, because it attempts to execute (with elevated privileges) multiple non-existent DLLs out of a non-existent standard-user writable location.

Frequently asked questions

What is CVE-2022-48225?: An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is used to install drivers from several different vendors. The Gemalto Document Reader child installation process is vulnerable to DLL hijacking, because it attempts to execute (with elevated privileges) multiple non-existent DLLs out of a non-existent standard-user writable location.
How severe is CVE-2022-48225?: CVE-2022-48225 has a CVSS 3.x base score of 7.3, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-48225 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-48225?: CVE-2022-48225 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-48225?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-48225 published?: CVE-2022-48225 was published on 2023-04-04 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:*

More vulnerabilities in Gbgplc Acuant Acufill Sdk

CVE-2022-48222 — High (CVSS 7.8): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK installation, certutil.exe is called by…
CVE-2022-48226 — High (CVSS 7.8): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of…
CVE-2022-48221 — High (CVSS 7.5): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user…
CVE-2022-48224 — High (CVSS 7.3): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write…
CVE-2022-48223 — Medium (CVSS 6.7): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK repair, certutil.exe is called by the…

All CVEs affecting Gbgplc Acuant Acufill Sdk →

Other CWE-427 (Uncontrolled Search Path Element) vulnerabilities

CVE-2025-4981 — Critical (CVSS 9.9): Mattermost versions 10.5.x <= 10.5.5, 9.11.x <= 9.11.15, 10.8.x <= 10.8.0, 10.7.x <= 10.7.2, 10.6.x <= 10.6.5 fail to…
CVE-2025-69599 — Critical (CVSS 9.8): RayVentory Scan Engine through 12.6 Update 8 allows attackers to gain privileges if they control the value of the PATH…
CVE-2019-25268 — Critical (CVSS 9.8): NREL BEopt 2.8.0.0 contains a DLL hijacking vulnerability that allows attackers to load arbitrary libraries by tricking…
CVE-2023-53959 — Critical (CVSS 9.8): FileZilla Client 3.63.1 contains a DLL hijacking vulnerability that allows attackers to execute malicious code by…
CVE-2025-65741 — Critical (CVSS 9.8): Sublime Text 3 Build 3208 or prior for MacOS is vulnerable to Dylib Injection. An attacker could compile a .dylib file…
CVE-2024-23054 — Critical (CVSS 9.8): An issue in Plone Docker Official Image 5.2.13 (5221) open-source software that could allow for remote code execution…

Browse all CWE-427 (Uncontrolled Search Path Element) vulnerabilities →